This invention relates to the use of polyanionic benzylglycosides as smooth muscle cell proliferation inhibitors and as therapeutic compositions for treating diseases and conditions which are characterized by excessive smooth muscle proliferation, such as restenosis. The compounds of this invention are those of formula I ##STR1## wherein each of R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are, independently, H, SO.sub.3 M, or ##STR2## and each oligosaccharide group contains 1 to 3 sugar groups; M is lithium, sodium, potassium, or ammonium; n is 1 or 2; X is a halogen, lower alkyl having 1 to 6 carbon atoms, or lower alkoxy having 1 to 6 carbon atoms; Y is carbonyl or sulfonyl; Z is alkyl from 1 to 12 carbon atoms, ##STR3## and X is as defined above; or a pharmaceutically acceptable salt thereof.
本发明涉及使用聚阴离子苯基糖苷作为平滑肌细胞增殖
抑制剂和治疗组合物,用于治疗由于过度平滑肌增殖而表现出的疾病和症状,如再狭窄。本发明的化合物具有以下式I的结构:
其中R^1、R^2、R^3和R^4中的每一个独立地为H、SO3M或##STR2##,每个
寡糖基团含有1到3个糖基;M为
锂、
钠、
钾或
铵;n为1或2;X为卤素、具有1到6个碳原子的低烷基,或具有1到6个碳原子的低烷氧基;Y为羰基或磺基;Z为1到12个碳原子的烷基、##STR3##和X如上定义;或其药学上可接受的盐。